Covered recipient · General Payments record
WILEY M DAVIS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$5,015.98
- Reported across 197 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,135.59 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $538.66 | 21 |
| Acerta Pharma LLC | $344.20 | 4 |
| Amgen Inc. | $198.80 | 10 |
| ABBVIE INC. | $53.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $53.93 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103610472 | CMS |
| Amgen Inc. | $9.34 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117537008 | CMS |
| Amgen Inc. | $9.30 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117537010 | CMS |
| Amgen Inc. | $7.16 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117537012 | CMS |
| Amgen Inc. | $119.81 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117537026 | CMS |
| Amgen Inc. | $9.56 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117537014 | CMS |
| Amgen Inc. | $8.45 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117537016 | CMS |
| Amgen Inc. | $11.82 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117537018 | CMS |
| Amgen Inc. | $5.81 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117537020 | CMS |
| Amgen Inc. | $7.63 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117537022 | CMS |
| Amgen Inc. | $9.92 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117537024 | CMS |
| AstraZeneca Pharmaceuticals LP | $101.32 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104599042 | CMS |
| AstraZeneca Pharmaceuticals LP | $6.48 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104625330 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105521287 | CMS |
| AstraZeneca Pharmaceuticals LP | $111.40 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105494971 | CMS |
| Novo Nordisk Inc | $7.46 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096922166 | CMS |
| Novo Nordisk Inc | $5.43 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097047636 | CMS |
| Novo Nordisk Inc | $7.31 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097749370 | CMS |
| Novo Nordisk Inc | $125.00 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096732924 | CMS |
| Novo Nordisk Inc | $10.42 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096596956 | CMS |
| Novo Nordisk Inc | $10.85 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097465795 | CMS |
| Novo Nordisk Inc | $11.11 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097739646 | CMS |
| Novo Nordisk Inc | $10.48 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096847876 | CMS |
| Novo Nordisk Inc | $7.74 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096674338 | CMS |
| Novo Nordisk Inc | $9.83 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097345501 | CMS |
| Novo Nordisk Inc | $10.28 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096753925 | CMS |
| Novo Nordisk Inc | $6.14 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097314559 | CMS |
| Novo Nordisk Inc | $5.98 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096653782 | CMS |
| Novo Nordisk Inc | $6.80 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096904399 | CMS |
| Novo Nordisk Inc | $125.00 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097584256 | CMS |
| Novo Nordisk Inc | $7.13 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097665780 | CMS |
| Novo Nordisk Inc | $13.93 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097594106 | CMS |
| Novo Nordisk Inc | $14.36 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096788794 | CMS |
| Novo Nordisk Inc | $121.16 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096871206 | CMS |
| Novo Nordisk Inc | $6.45 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096599801 | CMS |
| Novo Nordisk Inc | $15.80 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097043232 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.